Envista names three new executives; Nobel Biocare president exits Dec 31

Envista Holdings Corp

Patrik Eriksson, SVP and President of Nobel Biocare, departs effective Dec 31, 2023.
Robert Befidi appointed President, Diagnostics; previously led division at 3M.
Suraj Satpathy appointed Chief Human Resources Officer; formerly SVP HR at Cepheid.
Andrew Chen appointed Chief Information Officer; previously CIO at Kite Pharma.
External search for permanent CFO is underway; CEO Aghdaei directly overseeing Nobel Biocare.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Patrik Eriksson

SVP and President, Nobel Biocare

NVST · Envista Holdings Corp

Effective: 2023-12-31
Filed: December 14, 2023, 6:59 PM ET

On December 11, 2023, Envista Holdings Corporation (the “Company”) and Patrik Eriksson, the Company’s SVP and President, Nobel Biocare, mutually agreed that Mr. Eriksson’s employment will terminate effective December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrik Eriksson resigned as SVP and President, Nobel Biocare at Envista Holdings Corp.

Action: resigned
Role: SVP and President, Nobel Biocare

Exact text from the filing

On December 11, 2023, Envista Holdings Corporation (the “Company”) and Patrik Eriksson, the Company’s SVP and President, Nobel Biocare, mutually agreed that Mr. Eriksson’s employment will terminate effective December 31, 2023.

View on SEC.gov

Envista Holdings Corp filing history →

Source: SEC EDGAR

accession 0001757073-23-000078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.